About Angiografia De Occidente S.A.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Angiografia De Occidente S.A.
During the past decade, Angiografia De Occidente S.A. conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on
average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Angiografia De Occidente S.A." #1 sponsor was "Amaranth Medical Inc." with 3 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Eurocor GmbH" with 1 trials sponsored and "Kona Medical Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
Clinical Trials Conditions at Angiografia De Occidente S.A.
According to Clinical.Site data, the most researched conditions in "Angiografia De Occidente S.A." are
"Coronary Artery Disease" (4 trials), "Myocardial Ischemia" (3 trials), "Aortic Valve Stenosis" (2 trials), "Hepatocellular Carcinoma" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "Angiografia De Occidente S.A." in a lesser frequency.
Clinical Trials Intervention Types at Angiografia De Occidente S.A.
Most popular intervention types in "Angiografia De Occidente S.A." are "Device" (9 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (1 trials), "AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials), "AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials), "AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Angiografia De Occidente S.A.
The vast majority of trials in "Angiografia De Occidente S.A." are
11 trials for "All" genders.
Clinical Trials Status at Angiografia De Occidente S.A.
Currently, there are NaN active trials in "Angiografia De Occidente S.A.".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Angiografia De Occidente S.A.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Angiografia De Occidente S.A., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".